10-K · April 15, 2026
Selectis Health (formerly Global Healthcare REIT) has been shifting toward an owner-operator model since 2019 and currently focuses on senior housing and post-acute/skilled nursing operations in the South/Southeast U.S.…
Earnings analysis · 10-Q
GBCS earnings analysis
Filed August 24, 2026 · Our reading of the company's report
The latest report
The extracted Form 10-Q text does not include income statement, segment, balance-sheet, or cash-flow figures, so operating trends and free cash flow cannot be assessed from the available filing content. The principal…
Read full summary
The extracted Form 10-Q text does not include income statement, segment, balance-sheet, or cash-flow figures, so operating trends and free cash flow cannot be assessed from the available filing content. The principal disclosure is significant control weakness: disclosure controls were ineffective as of June 30, 2026, and two material weaknesses remained unremediated. A Utah-law issue also required $401,000 to be reclassified from equity to liabilities, while remediation is planned for 2026.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Management Supports Financial Statement Presentation
Management stated that the financial statements present fairly in all material respects after performing additional analysis in response to the disclosed control weaknesses.
-
Control Remediation Planned for 2026
The Company plans to implement multi-level review in 2026 and intends to work with internal personnel and third parties to strengthen controls.
-
No Further Quarterly Control Change Reported
Management reported no change during the quarter ended June 30, 2026 that materially affected, or was reasonably likely to materially affect, internal control over financial reporting.
What to watch
-
Ineffective Disclosure Controls
Disclosure controls and procedures were concluded to be ineffective as of June 30, 2026, meaning they did not provide assurance that required information would be timely recorded, processed, summarized, and reported.
-
Unremediated Review Weakness
The material weakness identified during preparation of the 2025 Form 10-K, involving inadequate multi-level review and untimely account and reconciliation reviews, was not remediated as of June 30, 2026 and could permit a material misstatement.
-
Preferred Stock Classification Issue
A Utah-law technical defect involving the historical issuance of Series A Convertible Preferred Stock required $401,000 previously classified as equity to be reported as a liability and led management to identify a material weakness relating to complex equity transactions; that weakness was not remediated as of June 30, 2026.
Management's outlook
No quantitative revenue or EPS outlook is provided in the extracted Form 10-Q text.
Earlier filings 4
10-Q · August 14, 2025
Selectis Health reported Q2 2025 revenue of $10,441,244, up versus Q2 2024 revenue of $9,584,802, driven by healthcare revenue growth. Operating loss narrowed and cash from operations turned positive year-to-date, but…
10-Q · May 21, 2025
Selectis Health reported Q1 2025 revenue of $10,486,939 (up $994,533 or 10.48% vs Q1 2024's $9,492,406) and a smaller net loss of $655,969 (EPS -$0.22 vs -$0.34). Operating cash flow strengthened to $1,035,411 and free…
10-K · April 15, 2025
Selectis Health (GBCS) continued its strategic shift from a landlord REIT to an owner-operator of senior housing and post-acute facilities, reporting that it owns 12 healthcare facilities and operates nine as of…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.